BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Prostate
,
DNA fingerprint
,
Fenofibrate
,
rs2300478
,
MDM2
,
Metabolism of xenobiotics
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Pancreatic islets treated with CMPF (3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid)
Explore Curated Studies Results
Literature
Most Relevant Literature
Evolution of protein-bound uraemic solutes during predilution haemofiltration.
Influences of haemodialysis on the binding sites of human serum albumin: possibility of an efficacio…
New approaches to the removal of protein-bound toxins from blood plasma of uremic patients.
Involvement of organic anion transporters in the efflux of uremic toxins across the blood-brain barr…
Effects of uremic toxins on hepatic uptake and metabolism of erythromycin.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
There were no clinical trials for 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ